Case Review Form

      * Denotes required field.

      Title

      * First Name

      * Last Name

      * Email Address

      * Phone Number

      Cell Phone Number

      Office Phone Number

      Street Address

      Apartment/Suite

      City

      State

      Zip Code

      Please provide the best method and times to contact you:

      Date of birth of injured person
      (mm-dd-yyyy):

      Name of drug:

      Date you started taking the drug (mm-yyyy):

      Date you stopped taking the drug (mm-yyyy):

      Please describe any side effects:

      Other Info:

      No Yes, I agree to the Parker & Waichman LLP disclaimers.Click here to review all.

      Yes, I would like to receive the Parker & Waichman LLP monthly newsletter, InjuryAlert.

      please do not fill out the field below.

Parker Waichman representing Maryland man in latest Plavix hemorrhaging lawsuit

Filed August 22nd, 2012 Joshua Sophy

A Maryland man is the latest to claim the blood thinner Plavix caused severe hemorrhaging and has filed a lawsuit against its maker, blaming Bristol-Myers Squibb and Sanofi-Aventis for overstating the benefits and hiding the dangers of its so-called “super aspirin.”

The man is being represented by the national law firm of Parker Waichman LLP, which represents a growing number of people who also claim they took Plavix at the recommendation of their doctors to thin the blood in the prevention of blood clots, heart attack, and stroke.

The Marylander represented by the Parker Waichman lawsuit filed in New York Supreme Court claims to have taken Plavix from 2004 until 2011. It was then that he suffered an Epidural hematoma/hemorrhage that caused severe and permanent injuries. His lawsuit is seeking damages for physical impairment and disfigurement, pain and suffering, loss of enjoyment of life, and economic damages, according to the firm’s announcement of the filing.

The pharmaceutical firms behind Plavix held firm to the results of just one clinical study which showed that its drug was more effective than regular aspirin as a blood thinner in the prevention of heart attacks and stroke that could lead to death. Plavix has even been dubbed a “super aspirin” in marketing materials but in clinical trials using scientific evidence, the drug has not stood up to those claims, often performing equally to or less than ordinary aspirin. Moreover, taking Plavix also puts patients at risk of suffering severe hemorrhaging that could lead to death.

Plavix was sold at a premium, compared to the cost of aspirin, which is just pennies a day.

Be Sociable, Share!

Comments are closed.

Click Here Now, to Have an Attorney Answer Your
Medicinal Drug Injuries Questions
No Cost - No Obligation!